FDA Inspection 882356 — Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. on May 16, 2014 in Dongyang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 16, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dongyang (China)